Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-85
SponsorOslo University Hospital

About this trial

Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options.

The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification.

Persistent pain for at least 3 months, with documented failure of conservative treatment

Age ranging from 60 years of age to 85 years of age

Disqualifiers

Significant shoulder osteoarthritis in the affected shoulder, Hamada classification >2.

Total rupture of subscapularis tendon and/or teres minor, classified B and E in the Collins classification.

Comorbidity to the degree that the patient will not be able to participate in the follow up program.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Biodegradable spacer

    Procedure/Surgery

    Implantation of a biodegradable balloon used as a subacromial spacer.

  • Debridement and biceps tenotomy

    Procedure/Surgery

    Surgery with arthroscopic debridement and biceps tenotomy

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Group A: Biodegradable spacerExperimental treatment 2 interventions
Group B: Group B: control groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Constant score

A well review score that takes several factors in to account: active range of motion, activities of daily living, pain and strength. A person with a normal, healthy shoulder should score 100 points, which is maximum score. Constant score is seen as a relatively objective test, as the testing will be performed by a physiotherapist.

Time frame
Preop, 6 months, 1 year, 2 years, 5 years, 10 years.

Secondary outcomes

1

WORC

Western Ontario Rotator Cuff Index is a questionnaire that explores 5 domains: physical symptoms, sports and recreation, work, social function, emotions.

Time frame
Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years
2

X-ray of the shoulder

Measure the height from the head of the humerus to the acromion

Time frame
Preop. Postop: 1. day, 1 year, 2 years, 5 years, 10 years
3

VAS

Visual analog scale for pain in rest, activity and at night. Scale from 0 til 10.

Time frame
Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years
4

Eq-5D

Questionaire for daily activity

Time frame
Preop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.